4.58

3.17% -0.15

Handel nachbörslich: 4.60 0.02 +0.44%

Outset Medical Inc (OM)

Überblick Nachrichten Preisverlauf Optionskette Financials Warum fällt OM? Forum Prognose

Schlusskurs vom Vortag:

$4.73

Offen:

$4.63

24-Stunden-Volumen:

128.57K

Relative Volume:

0.75

Marktkapitalisierung:

$84.90M

Einnahmen:

$117.59M

Nettoeinkommen (Verlust:

$-74.85M

KGV:

-1.097

EPS:

-4.175

Netto-Cashflow:

$-34.25M

1W Leistung:

-6.34%

1M Leistung:

-3.98%

6M Leistung:

+4.33%

1J Leistung:

-77.17%

1-Tages-Spanne:

$4.56

$4.84

1-Wochen-Bereich:

$4.51

$5.14

52-Wochen-Spanne:

$3.00

$21.98

Outset Medical Inc Stock (OM) Company Profile

Firmenname

Outset Medical Inc

Sektor

Healthcare (1102)

Branche

Medical Devices (141)

Telefon

669-231-8200

Adresse

3052 ORCHARD DRIVE, SAN JOSE

Mitarbeiter

310

Twitter

Nächster Verdiensttermin

2026-05-07

Neueste SEC-Einreichungen

OM's Discussions on Twitter

Compare OM vs ABT, SYK, MDT, BSX, EW

Aktien	Preis	Marktkapitalisierung	Umsatz	Nettogewinn	Free Cashflow	ENV
OM Outset Medical Inc	4.58	87.68M	117.59M	-74.85M	-34.25M	-4.175
ABT Abbott Laboratories	91.07	158.12B	45.13B	6.28B	7.38B	3.5895
SYK Stryker Corp	305.66	115.47B	25.27B	3.34B	4.57B	8.6334
MDT Medtronic Plc	81.67	105.19B	36.36B	4.84B	5.43B	3.7212
BSX Boston Scientific Corp	48.55	72.61B	20.62B	3.56B	3.48B	2.3847
EW Edwards Lifesciences Corp	85.96	50.35B	6.30B	1.07B	1.09B	1.8406

Outset Medical Inc Stock (OM) Upgrades & Downgrades

Datum	Aktion	Analytiker	Ratingänderung
2024-08-08	Herabstufung	RBC Capital Mkts	Outperform → Sector Perform
2024-06-21	Hochstufung	RBC Capital Mkts	Sector Perform → Outperform
2024-04-08	Eingeleitet	BTIG Research	Buy
2024-04-05	Hochstufung	CL King	Neutral → Buy
2024-01-12	Herabstufung	RBC Capital Mkts	Outperform → Sector Perform
2023-10-13	Herabstufung	BofA Securities	Buy → Underperform
2023-08-17	Eingeleitet	CL King	Neutral
2022-11-11	Eingeleitet	RBC Capital Mkts	Outperform
2022-07-14	Herabstufung	Morgan Stanley	Overweight → Equal-Weight
2022-03-02	Fortgesetzt	BofA Securities	Buy
2022-02-17	Hochstufung	Morgan Stanley	Equal-Weight → Overweight
2021-08-18	Eingeleitet	Cowen	Outperform
2021-04-19	Eingeleitet	Wells Fargo	Overweight
2020-12-16	Eingeleitet	Oppenheimer	Perform
2020-10-12	Eingeleitet	Barclays	Overweight
2020-10-12	Eingeleitet	BofA Securities	Buy
2020-10-12	Eingeleitet	Goldman	Buy
2020-10-12	Eingeleitet	Morgan Stanley	Equal-Weight
2020-10-12	Eingeleitet	SVB Leerink	Mkt Perform
2020-10-12	Eingeleitet	Stifel	Buy

Alle ansehen

Outset Medical Inc Aktie (OM) Neueste Nachrichten

Jun 05, 2026

Director at Outset Medical (OM) receives 10,667-share stock grant - Stock Titan

Jun 05, 2026

Outset Medical CFO Renee Gaeta sells $87,299 in stock By Investing.com - Investing.com Canada

Jun 05, 2026

Outset Medical CFO Renee Gaeta sells $87,299 in stock - Investing.com

Jun 05, 2026

Outset Medical (NYSE: OM) director granted 10,667 RSUs in new equity award - Stock Titan

Jun 05, 2026

Outset Medical (OM) director receives 10,667-share RSU equity grant - Stock Titan

Jun 05, 2026

Outset Medical (OM) director receives 10,667-share RSU-based award - Stock Titan

Jun 05, 2026

Outset Medical (OM) director receives 10,667-share equity award grant - Stock Titan

Jun 05, 2026

Outset Medical director granted 10,667 shares | OM Insider Trading - Stock Titan

Jun 05, 2026

Outset Medical (OM) CFO tax-related share sale follows RSU vesting - Stock Titan

Jun 05, 2026

Outset Medical (NASDAQ: OM) reports 2026 shareholder meeting vote results - Stock Titan

Jun 05, 2026

Did Outset Medical, Inc. Insiders Breach their Fiduciary Duties to Shareholders? - PR Newswire

Jun 05, 2026

Jun 04, 2026

Outset Medical names Derick Elliott commercial chief - Investing.com

Jun 04, 2026

Jun 03, 2026

OM (NASDAQ) Form 144 notice — 32,856 shares settled from RSUs - Stock Titan

Jun 03, 2026

DaVita Gains 21.4% in Three Months: How Should You Play the Stock? - Yahoo Finance

Jun 03, 2026

Jun 02, 2026